Drugs / Provex CV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01106170 | Mar 2010 → Oct 2011 | hypertensive disorder | University of Utah | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Provex CV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01106170 ↗ |
| Action | Activate | “potentiating eNOS activation and nitric oxide production” PMID 26059745 ↗ Jun 2015 |
| Route | Oral | “by mouth” NCT01106170 ↗ |